Extreme Chronic Undervalue, page-84

Needle, I agree it could and should have been handled differently. At this point, it's "crying over spilt milk", though.

My bet's that covid's going to get worse with all the impatient citizens and governments. Markets will follow and risk-on spending is going to be reduced. That would include retail buyers, funds and capital markets.

We'll see, I could be wrong. Been wrong before but have done something right to be sitting here typing this crap without having to worry about my next meal, car payment, mortgage payment, etc.

My point is, Kazia has money now without having to yield on any partnership terms for at least a year or so. By that time the value of Paxalisib should be more obvious AND the risk-on / market outlook should be much better.

Just my 2 cents.